SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E
http://www.w3.org/2000/01/rdf-schema#comment
"Na+/K+-ATPase alpha3 might serve as a therapeutic target for bufalin and its expression status may help predict sensitivity of hepatocellular carcinoma cells to bufalin treatment."
xsd:string
http://purl.uniprot.org/uniprot/#_CA7A713C2FD85F16725B927538565E36ABAE06188090B310326E2652C6FEC5F4F2E1F7FAAA56C35E16A3667876028928
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E
http://purl.uniprot.org/uniprot/Q53ES0
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E
http://purl.uniprot.org/uniprot/#_Q53ES0-mappedCitation-21181095
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/7C8D94916DBBC1C1C7E5B9B20E78438CBF7942652A329BE0111393987A5FB5A1BB0E98DBD7BF52DB8F57F21F66F3711E